The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | B | Blood and blood forming organs | |
| 2 | B03 | Antianemic preparations | |
| 3 | B03A | Iron preparations | |
| 4 | B03AC | Iron trivalent, parenteral preparations |
| Active Ingredient | Description | |
|---|---|---|
| Ferumoxytol |
Ferumoxytol (USAN) is a dark-brown substance, which consists of nano-sized super paramagnetic iron (III)-oxide-cores coated with a small-sized carbohydrate shell of polyglucose sorbitol carboxymethylether (PSC). |
|
| Iron dextran |
|
|
| Iron (III) isomaltoside |
Iron(III) complex enables a controlled and slow release of bioavailable iron to iron-binding proteins with little risk of free iron. Evidence of a therapeutic response can be seen within a few days of administration of iron(III) as an increase in the reticulocyte count. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| DIAFER Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| FERINJECT Solution for injection/infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| FERRLECIT Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| MONOFER Solution for injection / infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| MONOFERRIC Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| MONOVER Solution for injection / infusion | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
| VENOFER Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
